A Phase I Trial Of The Intravenous (Iv) Hsp90 Inhibitor 17-Dmag (Alvespimycin) In Patients (Pts) With Relapsed Chronic Lymphocytic Leukemia (Cll)/Small Lymphocytic Lymphoma (Sll)
BLOOD（2012）
摘要
Abstract 1800
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要